Supreme Court Seems Ready To Uphold Ruling Against Amgen’s Anti-PCSK9 Antibody Patents

 
• By Brenda Sandburg

Justices question what Amgen’s invention covers in its dispute with Sanofi. They appear inclined to uphold Federal Circuit’s standard for enablement despite potential negative impact on genus claims.

Supreme Court long shot
Supreme Court hears oral argument in Amgen v. Sanofi PCSK9-targeting antibodies case • Source: Brenda Sandburg

More from Legal & IP

More from Pink Sheet